Get started
Author

Takuma Onoe

Observed names: T Onoe, T. Onoe, TAKUMA ONOE
Observed institution: Hyogo Prefectural Cancer Center
ORCID: 0000-0003-3676-5294
Observed ORCID: 0000-0003-3676-5294
OpenAlex ID: A5050286593
Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site
2019 · Hidetoshi Hayashi, Takayasu Kurata, et al. · Journal of Clinical Oncology · 174
Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02)
2018 · M. Tahara, N. Kiyota, et al. · Annals of Oncology · 99
Immunotherapy for squamous cell carcinoma of the head and neck
2020 · Tomoya Yokota, Akihiro Homma, et al. · Japanese Journal of Clinical Oncology · 57
Systemic therapy for salivary gland malignancy: current status and future perspectives
2022 · Yoshinori Imamura, Naomi Kiyota, et al. · Japanese Journal of Clinical Oncology · 35
PDF
PARP inhibitors for BRCA wild type ovarian cancer; gene alterations, homologous recombination deficiency and combination therapy
2019 · Koji Matsumoto, Meiko Nishimura, et al. · Japanese Journal of Clinical Oncology · 34
PDF
4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study
2014 · Naoto Takase, Koji Matsumoto, et al. · International Journal of Clinical Oncology · 32
A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody
2024 · T. Koyama, N. Kiyota, et al. · ESMO Open · 31
PDF
Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck
2020 · Susumu Okano, Akihiro Homma, et al. · Japanese Journal of Clinical Oncology · 31
Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02).
2016 · Makoto Tahara, Naomi Kiyota, et al. · Journal of Clinical Oncology · 27
Phase 1 dose‐escalation study of single‐agent veliparib in Japanese patients with advanced solid tumors
2017 · Tadaaki Nishikawa, Koji Matsumoto, et al. · Cancer Science · 24
PDF
Proposal for Managing Cancer‐Related Insomnia: A Systematic Literature Review of Associated Factors and a Narrative Review of Treatment
2024 · Yoshinori Saeki, Yukiyoshi Sumi, et al. · Cancer Medicine · 18
PDF
Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer
2019 · Susumu Okano, Tomohiro Enokida, et al. · International Journal of Clinical Oncology · 17
Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B)
2021 · Takamichi Yokoe, Sasagu Kurozumi, et al. · Breast Cancer · 15
PDF
Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study
2026 · Lisa Licitra, Makoto Tahara, et al. · Journal of Clinical Oncology · 11
4-step, 2-h carboplatin desensitization in Japanese patients with ovarian cancer: a prospective study
2021 · Meiko Nishimura, Hideki Sakai, et al. · International Journal of Clinical Oncology · 9
PDF
A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer
2025 · Yoshiaki Nagatani, Naomi Kiyota, et al. · Japanese Journal of Clinical Oncology · 7
PDF
Safety and Relative Dose Intensity of Dose-dense Doxorubicin and Cyclophosphamide Followed by Dose-dense Paclitaxel
2019 · MEIKO NISHIMURA, TAKUMA ONOE, et al. · Anticancer Research · 6
PDF
Indications for chemoradiotherapy in older patients with locally advanced head and neck cancer in Japan: a questionnaire survey in the JCOG head and neck cancer study group
2025 · Koichi Yasuda, Naomi Kiyota, et al. · Frontiers in Oncology · 5
A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer.
2023 · Yoshiaki Nagatani, Naomi Kiyota, et al. · Journal of Clinical Oncology · 5
PDF
Regorafenib as second-line therapy for imatinib-resistant gastrointestinal stromal tumor (GIST).
2020 · Tsuyoshi Takahashi, Toshirou Nishida, et al. · Journal of Clinical Oncology · 4
Human papillomavirus-related oropharyngeal carcinoma
2022 · Yuki Saito, Akihiro Homma, et al. · Japanese Journal of Clinical Oncology · 3
Successful Complete Resection of Primary Cardiac Synovial Sarcoma Invading Right Atrium Wall
2024 · Kana Nagasawa, Takanori Kusuyama, et al. · JACC Case Reports · 2
A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody.
2023 · Taiji Koyama, Naomi Kiyota, et al. · Journal of Clinical Oncology · 2
PDF
Optimal Sunitinib Dosing Based on Platelet Count in an Older Patient With Gastrointestinal Stromal Tumor
2025 · HIROTAKA SUTO, MIYUKI KAWAMURA, et al. · In Vivo · 1
Corrigendum: Indications for chemoradiotherapy in older patients with locally advanced head and neck cancer in Japan: a questionnaire survey in the JCOG head and neck cancer study group
2025 · Koichi Yasuda, Naomi Kiyota, et al. · Frontiers in Oncology · 1
PDF
Works count: 50
Citation count: 655
H-index: 13
I10-index: 14
Year
Topic
Type